首页> 美国卫生研究院文献>OncoTargets and therapy >The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers
【2h】

The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers

机译:N6-甲基苯胺(M6A)去甲基酶脂肪质量和肥胖相关基因(FTO)在人类癌症中的潜在作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

N6-methyladenosine (m6A) demethylase fat mass and obesity-associated gene(FTO), previously recognized to be related with obesity and diabetes, was gradually discovered to be dysregulated in multiple cancers and plays an oncogenic or tumor-suppressive role. However, the specific expression and pro- or anti-cancer role of FTO in various cancers remained controversial. In this review, through summarizing the available literature, we found that FTO single nucleotide polymorphisms (SNPs) were closely related with cancer risk. Additionally, the dysregulation of FTO was implicated in multiple biological processes, such as cancer cell apoptosis, proliferation, migration, invasion, metastasis, cell-cycle, differentiation, stem cell self-renewal and so on. These modulations mostly relied on the communications between FTO and specific signaling pathways, including PI3K/AKT, MAPK and mTOR signaling pathways. Furthermore, FTO had great potential for clinical application by serving as a prognostic biomarker.
机译:以前认可与肥胖和糖尿病相关的N6-甲基腺苷(M6A)去甲基酶脂肪质量和肥胖相关的基因(FTO)被逐步发现在多种癌症中具有抑制和致癌或肿瘤抑制作用。然而,各种癌症中FTO的特异性表达和抗癌作用仍然存在争议。在本综述中,通过总结可用文献,我们发现FTO单核苷酸多态性(SNPs)与癌症风险密切相关。另外,FTO的失调涉及多种生物过程,例如癌细胞凋亡,增殖,迁移,侵袭,转移,细胞周期,分化,干细胞自我更新等。这些调制主要依赖于FTO和特定信令路径之间的通信,包括PI3K / AKT,MAPK和MTOR信令路径。此外,通过用作预后生物标志物,FTO对临床应用具有很大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号